We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-6.97%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$10.4B
AUM Growth
-$1.52B
Cap. Flow
-$723M
Cap. Flow %
-6.93%
Top 10 Hldgs %
32.83%
Holding
1,239
New
73
Increased
466
Reduced
278
Closed
97

Sector Composition

Rank Sector Weight
1 Real Estate 74.77%
2 Technology 3.37%
3 Industrials 3.06%
4 Financials 2.76%
5 Healthcare 2.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
1051
Lexicon Pharmaceuticals
LXRX
$1.02B
$4K ﹤0.01%
583
PBYI icon
1052
Puma Biotechnology
PBYI
$406M
$4K ﹤0.01%
207
REPL icon
1053
Replimune Group
REPL
$814M
$4K ﹤0.01%
+350
New +$4.73K
TECX
1054
Tectonic Therapeutic
TECX
$573M
$4K ﹤0.01%
+21
New +$6.4K
RVNC
1055
DELISTED
Revance Therapeutics, Inc.
RVNC
$4K ﹤0.01%
202
IMGN
1056
DELISTED
Immunogen Inc
IMGN
$4K ﹤0.01%
731
ACOR
1057
DELISTED
Acorda Therapeutics
ACOR
$4K ﹤0.01%
2
ATNX
1058
DELISTED
Athenex, Inc. Common Stock
ATNX
$4K ﹤0.01%
16
RDUS
1059
DELISTED
Radius Health, Inc.
RDUS
$4K ﹤0.01%
246
BOLD
1060
DELISTED
Audentes Therapeutics, Inc
BOLD
$4K ﹤0.01%
165
ALDR
1061
DELISTED
Alder Biopharmaceuticals
ALDR
$4K ﹤0.01%
374
NFX
1062
DELISTED
Newfield Exploration
NFX
$4K ﹤0.01%
262
-6,300
-96% -$127K
ANIP icon
1063
ANI Pharmaceuticals
ANIP
$1.77B
$3K ﹤0.01%
64
AUPH icon
1064
Aurinia Pharmaceuticals
AUPH
$1.97B
$3K ﹤0.01%
464
CERS icon
1065
Cerus
CERS
$587M
$3K ﹤0.01%
630
CHRS icon
1066
Coherus Oncology
CHRS
$217M
$3K ﹤0.01%
320
COLL icon
1067
Collegium Pharmaceutical
COLL
$1.14B
$3K ﹤0.01%
180
CTMX icon
1068
CytomX Therapeutics
CTMX
$705M
$3K ﹤0.01%
212
MGNX icon
1069
MacroGenics
MGNX
$235M
$3K ﹤0.01%
203
NTLA icon
1070
Intellia Therapeutics
NTLA
$1.5B
$3K ﹤0.01%
234
NVAX icon
1071
Novavax
NVAX
$1.23B
$3K ﹤0.01%
87
OMER icon
1072
Omeros
OMER
$709M
$3K ﹤0.01%
265
WDAY icon
1073
PUT
Workday
WDAY
$33.4B
$3K ﹤0.01%
500
ITCI
1074
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3K ﹤0.01%
302
EGRX
1075
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3K ﹤0.01%
82

Similar funds

Daiwa Securities Group's Q4 2018 Portfolio in Review

As of Q4 2018, Daiwa Securities Group held 1,239 positions worth $10.4B, down 13% from $11.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Daiwa Securities Group withdrew a net $723M in Q4 2018, closing 97 positions and reducing 278 holdings. Its most notable exit was Steris, an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 75% of assets, up from 72% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in SITE Centers worth $138M.

  • Daiwa Securities Group's largest Q4 2018 buy was SITE Centers: 16,021,815 shares worth $138M.
  • Daiwa Securities Group added most to American Tower in Q4 2018, an estimated $128M increase.
  • Daiwa Securities Group's biggest Q4 2018 reduction was Crown Castle, cutting an estimated $211M.
  • Daiwa Securities Group fully exited Steris in Q4 2018, selling an estimated $11.9M.
  • Daiwa Securities Group's ten largest holdings make up 33% of its $10.4B portfolio in Q4 2018.
  • Daiwa Securities Group opened 73 new positions and closed 97 in Q4 2018.
  • Daiwa Securities Group's portfolio value fell 13% quarter-over-quarter to $10.4B.

Based on Daiwa Securities Group's 13F filing for Q4 2018, filed 5 Feb 2019.